Propranolol Market, By Product Type (Immediate-Release Propranolol, Extended-Release (Sustained-Release) Propranolol, and Injectable Propranolol), By Dosage Strength (20 to 40 mg, 60 to 80 mg, Up to 10 mg, and 100 mg and above), By Indication (Hypertension, Angina Pectoris, Arrhythmia, Migraine Prophylaxis, Anxiety Disorders (Performance/Social), Hyperthyroidism / Thyrotoxicosis, Essential Tremor, Infantile Hemangioma, Post-Myocardial Infarction Management, and Other Cardiovascular Indications), By Patient Demographics (Pediatric, Adult, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Government & Institutional Supply), By End User (Hospitals, Specialty Clinics (Cardiology, Neurology, Endocrinology), Ambulatory Surgical Centers, and Homecare Settings), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)